Skip to content

Oscar Health OSCR Benefits and CAE payable, beginning of period

Other financials

Income statement

See full
Revenue$4.6B+52.6%
Operating income$704.1M+137%
Net income$679.0M+147%
EPS (diluted)$2.07+125%

Balance sheet

See full
Cash & equivalents$4.8B+114%
Total debt$430.9M+43.7%
Total equity$1.7B+24.8%
Total assets$9.3B+59.0%

Cash flow

See full
Operating cash flow$2.6B+198%
CapEx$8.8M-2.6%
Free cash flow$2.6B+200%

Valuation

See full
Market cap$8.56B+4.0%
Enterprise value$4.16B-174%
P/S0.6×-0.2×

Profitability

See full
Operating margin0.1%
Net margin-0.3%
FCF margin-8.2%

Returns & leverage

See full
Return on equity-2.6%
Debt / equity0.3×0.0×
Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept oscr:LiabilityForClaimsAndClaimsAdjustmentExpenseAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAdjustments.

The official record: Oscar Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oscar Health's benefits and cae payable, beginning of period.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oscar Health's benefits and CAE payable, beginning of period?
Oscar Health (OSCR) reported benefits and CAE payable, beginning of period of $1.76B in Q1 2026.
How has Oscar Health's benefits and CAE payable, beginning of period changed year-over-year?
Oscar Health's benefits and CAE payable, beginning of period increased by 18.3% year-over-year, from $1.49B to $1.76B.
What is the long-term trend for Oscar Health's benefits and CAE payable, beginning of period?
Over 4 years (2021 to 2025), Oscar Health's benefits and CAE payable, beginning of period has grown at a 29.6% compound annual growth rate (CAGR), from $522.68M to $1.47B.